[EN] 2-ARYL-4-QUINOLINECARBOXAMIDE DERIVATIVES FOR TREATING THYROID DISEASES<br/>[FR] DÉRIVÉS 2-ARYL-4-QUINOLÉINECARBOXAMIDE POUR LE TRAITEMENT DE MALADIES DE LA THYROÏDE
申请人:ICAHN SCHOOL MED MOUNT SINAI
公开号:WO2016004035A1
公开(公告)日:2016-01-07
The use of 2-arylquinolinecarboxamides of formula (I): is disclosed. The compounds are agonists at the TSH receptor (TSHR) and are therefore useful in the treatment of patients with thyroid dysfunction and in the management of differentiated thyroid cancer.